Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer
Maria Rubinstein, Sherry Shen, Bradley J Monk, David S P Tan, Angélica Nogueira-Rodrigues, Daisuke Aoki, Jalid Sehouli, Vicky Makker DOI: 10.1016/j.ygyno.2022.10.012 Full link: https://linkinghub.elsevier.com/retrieve/pii/S0090825822018893
Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
Gabriela S M de Siqueira , Samir A Hanna , Larissa F de Moura , Fabiana Accioli Miranda , Heloísa de Andrade Carvalho, Gustavo Nader Marta DOI: 10.1016/j.lana.2022.100323 Full link: https://www.sciencedirect.com/science/article/pii/S2667193X22001405?via%3Dihub
In reply to Li et al. Letter to the editor. “Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.”
Gustavo A. Viani, Andre G. Gouveia, Fabio Y. Moraes DOI: 10.1016/j.radonc.2022.09.017 Full link: https://doi.org/10.1016/j.radonc.2022.09.017
Radiotherapy activity in the COVID 19 pandemic: Brazil’s operational national-level study
Fabio Y Moraes, Andre G Gouveia, Renato P Lima, Vanessa F Bratti, Ana C Hamamura, Gustavo A Viani DOI: 10.1016/j.jcpo.2022.100367 Full link: https://pubmed.ncbi.nlm.nih.gov/36216270/
Radiotherapy activity in the COVID 19 pandemic: Brazil’s operational national-level study
Fabio Y Moraes, Andre G Gouveia, Renato P Lima, Vanessa F Bratti, Ana C Hamamura, Gustavo A Viani DOI: 10.1016/j.jcpo.2022.100367 Full link: https://pubmed.ncbi.nlm.nih.gov/36216270/
435P Cisplatin versus mitomycin plus fluoropyrimidine and radiation for localized squamous cell carcinoma of the anus (SCCA): Final results of GTG-LACOG 1318 real-world data study
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
EP03.01-003 Clinical Features and Molecular Profile of Advanced Non-small Cell Lung Cancer in Latin America: LATINO Lung (LACOG 0116)
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
Adjuvant PD-1 and PD-L1 Inhibitors and Relapse-Free Survival in Cancer Patients: The MOUSEION-04 Study
Alessandro Rizzo, Veronica Mollica, Andrea Marchetti, Giacomo Nuvola, Matteo Rosellini, Elisa Tassinari, Javier Molina-Cerrillo, Zin W Myint, Tomas Buchler, Fernando Sabino Marques Monteiro, Enrique Grande, Matteo Santoni, Francesco Massari DOI: 10.3390/cancers14174142 Full link: https://www.mdpi.com/2072-6694/14/17/4142
Final results of the global and Asia cohorts of KAMILLA, a phase IIIB safety trial of trastuzumab emtansine in patients with HER2-positive advanced breast cancer
R Wuerstlein, P Ellis 2, F Montemurro, A Antón Torres, S Delaloge, Q Zhang, X Wang, S Wang, Z Shao, H Li, A Rachman, M Vongsaisuwon, H Liu, S Fear, C Peña-Murillo, C Barrios DOI: 10.1016/j.esmoop.2022.100561 Full link: https://www.esmoopen.com/article/S2059-7029(22)00189-2/fulltext
Triple-negative breast cancer and radiation therapy
Jordana de Faria Bessa, Gustavo Nader Marta DOI: 10.5603/RPOR.a2022.0025 Full link: https://journals.viamedica.pl/rpor/article/view/88873